JHW-007
JHW-007 is a cocaine analogue and a high affinity atypical dopamine reuptake inhibitor that is being researched for the treatment of cocaine addiction.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
JHW-007 is a cocaine analogue and a high affinity atypical dopamine reuptake inhibitor that is being researched for the treatment of cocaine addiction. JHW-007 has been found to blunt the psychostimulant effects of cocaine and reduce self-administration in rodents. JHW-007 exposure has been shown to block the conditioned place preference effects of cocaine.
JHW-007 may directly antagonize the autoregulatory dopamine D 2 receptor, a hypothesis that was developed following the observation of JHW-007's ability to inhibit D 2 receptor-mediated currents in the midbrain.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1368720653 under CC BY-SA 4.0; modifications have been made.